Activation of 17β-estradiol and estrone by dimethyldioxirane and inhibition of rat liver nuclear and nucleolar RNA synthesis in vitro

Carcinogenesis

Volumn 17, Issue 9, 1996, Pages 1957-1961

  Yu, Fu Li ^a   Bender, Wanda ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; DIMETHYLDIOXIRANE; EPOXIDE; ESTRADIOL; ESTRONE; NUCLEAR RNA; OXIDIZING AGENT; TAMOXIFEN; UNCLASSIFIED DRUG; GUANOSINE PHOSPHATE; RNA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; EPOXIDATION; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; RAT; RNA SYNTHESIS; ANIMAL; BIOSYNTHESIS; CELL NUCLEUS; DRUG EFFECT; KINETICS; LIVER; METABOLISM; OXIDATION REDUCTION REACTION;

5'-GUANYLIC ACID; ANIMALS; CELL NUCLEOLUS; CELL NUCLEUS; DIETHYLSTILBESTROL; EPOXY COMPOUNDS; ESTRADIOL; ESTRONE; KINETICS; LIVER; OXIDATION-REDUCTION; RATS; RNA; TAMOXIFEN;

EID: 0029662230     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.9.1957     Document Type: Article

References (54)

1. Wingo, P.A., Tong, T. and Bolden, S. (1995) Cancer statistics, 1995. CA Cancer J. Clin., 45, 8-30.
2. Fisher, B., Costantino, J.P., Redmond, C.K., Fisher, E.R., Wickerham, D.L. and Cronin, W.M. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl Cancer Inst., 86, 527-537.
3. Herbst, A.L., Ulfelder, H. and Poskauzer, D.C. (1971) Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med., 284, 878-881.
4. Dragan, Y.P., Xu, Y.-D. and Pitot, H.C. (1991) Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis. Prev. Med., 20, 15-26.
5. Greaves, P. Goionetilleke, R., Nunn, G., Topham, J. and Orton, T. (1993) Two-year carcinogenicity study of tamoxifen in Alderly Park Wistardeprived rats. Cancer Res., 53, 3919-3924.
6. Hard, G.C., Iatropoulos, M.J., Jordan, D., Radi, L., Kaltenberg, O.P., Imondi, A.R. and Williams, G.M. (1993) Major differences in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res., 53, 4534-4541.
7. Williams, G.M., Iatropoulos, M.J., Djordjevic, M.D. and Kaltenberg, O.P. (1993) The triphenylethylene drug tamoxifen is a strong liver carcinogen in rat. Carcinogenesis, 14, 315-317.
8. Greenberg, E.R., Barnes, A.B., Resseguie, Z. et al. (1984) Breast cancer in mothers given diethylstilbestrol in pregnancy. N. Engl. J. Med., 311, 1391-1398.
9. Harris, R.E., Namboodiri, K.K. and Wynder, E.L. (1992) Breast cancer risk: effects of estrogen replacement therapy and body mass. J. Natl Cancer Inst., 84, 1575-1582.
10. Toniolo, P.G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K.L., Shore, R.E., Strax, P. and Pasternack, B.S. (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl Cancer Res., 87, 190-197.
11. Li, J.J. and Li, S.A. (1990) Estrogen carcinogenesis in hamster tissues: a critical review. Endocrine Rev., 11, 524-531.
12. Wanless, I.R. and Medline, A. (1982) The role of estrogens as promoters of hepatic neoplasia. Lab. Invest., 46, 313-320.
13. Williams, G.M., Latropoulos, M., Cheung, R., Radi, L. and Wang, C.X. (1993) Diethylstilbestrol liver carcinogenicity and modification of DNA in rats. Cancer Lett., 68, 193-198.
14. Bhat, H.K., Han, X., Gladek, A. and Liehr, J.G. (1994) Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure. Carcinogenesis, 15, 2137-2142.
15. Han, X. and Liehr, J.G. (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res., 52, 1360-1363.
16. Pathak, D.N. and Bodell, J. (1994) DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems. Carcinogenesis, 15, 529-532.
17. Phillips, D.H., Hewer, A., White, I.N.H. and Farmer, P.B. (1994) Cochromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen-treated rats. Carcinogenesis, 15, 793-795.
18. Mani, C. and Kupfer, D. (1991) Cytochrome P450 mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver. Possible involvement of flavin-containing monoxygenases in tamoxifen activation. Cancer Res., 51, 6052-6058.
19. Styles, J.A., Davies, A., Lim, C.K., DeMatteis, F., Stanley, L.A., White, I.N.H., Yuan, Z.H. and Smith, L.L. (1994) Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis, 5, 5-9.
20. Potter, G.A., McCague, R. and Jarman, M. (1994) A mechanism hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism. Carcinogenesis, 15, 439-442.
21. Davies, A.M., Martin, E.A., Jones, R.M., Lim, C.K., Smith, L.L. and White, I.N.H. (1995) Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently-bound protein abducts. Carcinogenesis, 16, 539-545.
22. Pathak, D.N., Pongracz, K. and Bodell, W.J. (1995) Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Carcinogenesis, 16, 11-15.
23. Miller, E.C. and Miller, J.A. (1981) Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer, 47, 2327-2345.
24. Weisburger, E.K. (1980) Metabolism and activation of chemical carcinogens. Mol. Cell. Biochem., 32, 95-104.
25. Farber, E. (1984) Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes memorial lecture. Cancer Res., 44, 5463-5474.
26. Dipple, A. (1995) DNA adducts of chemical carcinogens. Carcinogenesis, 16, 437-441.
27. 32P-postlabelling test for DNA damage. Proc. Natl Acad. Sci. USA, 78, 6126-6129.
28. Harris, C.C. (1991) Chemical and physical carcinogenesis: advances and perspective for the 1990s. Cancer Res., 51 (Suppl.), 5023s-5044s.
29. Hemminki, K. (1993) DNA adducts, mutations and cancer. Carcinogenesis, 14, 2007-2012.
30. Toft, D. and Gorski, J.A. (1966) A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc. Natl Acad. Sci. USA, 55, 574-581.
31. Jensen, E.V., Suzuki, T., Kawashima, T., Stumpf, W.E., Jungblut, P.W. and DeSombre, E.R. (1968) A two step mechanism for the interaction of estradiol with rat uterus. Proc. Natl Acad. Sci. USA, 59, 632-638.
32. Grody, W.W., Schrader, W.T. and O'Malley, B.W. (1982) Activation, transformation and subunit structures of steroid hormone receptors. Endocrine. Rev., 3, 141-163.
33. Kumar, V.J. and Chambon, P. (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell, 55, 145-156.
34. Beato, M. (1989) Gene regulation by steroid hormones. Cell, 58, 335-344.
35. Murdoch, F.E. and Gorski, J. (1991) The role of ligand in estrogen receptor regulation of gene expression. Mol. Cell. Endocrinol., 78, C103-C108.
36. O'Malley, B.W., Tasi, S.Y., Bagchi, M., Weigel, N.L., Schrader, W.T. and Tasi, M.-J. (1991) Molecular mechanism of action of a steroid hormone receptor. Rec. Prog. Horm. Res., 47, 1-26.
37. Adam, W., Chan, Y.Y., Cremer, D., Gauss, J., Scheutzow, D. and Schindler, M. (1987) Spectral and chemical properties of dimethyldioxirane as determined by experiment and abinitio calculations. J. Org. Chem., 52, 2800-2803.
38. 1-8,9-epoxide. Carcinogenesis, 15, 1737-1741.
39. 1 inhibition of rat liver nucleolar RNA synthesis. J. Biol. Chem., 252, 3245-3251.
40. 1 inhibition of rat liver nucleolar RNA synthesis. J. Biol. Chem., 256, 3292-3297.
41. 1: the ultimate carcinogenic species. J. Am. Chem. Soc., 110, 7929-7931.
42. Park, K.K., Surh, Y.J., Stewart, B.C. and Miller, J.A. (1990) Synthesis and properties of vinyl-carbamate epoxide, a possible ultimate electrophilic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate. Biochem. Biophys. Res. Commun., 169, 1094-1098.
43. 1 to the chromatin components and the inhibition of RNA synthesis. Carcinogenesis, 9, 527-532.
44. 1 to rat liver nucleolar proteins and its effect on DNA-dependent RNA synthesis. Carcinogenesis, 9, 533-540.
45. Colditz, G.A., Hankinson, S.E., Hunter, D.J., Willett, W.C., Manson, J.E., Stampfer, M.J., Hennekens, C., Rosner, B. and Speizer, F.E. (1995) The use of estrogens and progestins and the risk of brest cancer in postmenopausal women. N. Engl. J. Med., 332, 1589-1593.
46. Venn, A., Watson, L., Lumley, J., Giles, G., King, C. and Healy, D. (1995) Beast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet, 346, 995-1000.
47. The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in post menopausal women. JAMA, 273, 199-208.
48. The Writing Group for the PEPI Trial (1996) Effects of hormone replacment therapy on endometrial histology in postmenopausal women. JAMA, 275, 370-375.
49. Busby, W.F. and Wogan, G.N. (1984) Aflatoxins. In Searle, C.E. (ed.), Chemical carcinogens, 2nd edn, ACS Monograph 182, American Chemical Society, Washington, DC, pp. 945-1136.
50. 1 inhibition of nuclear RNA polymerase II activity. Carcinogenesis, 3, 1005-1009.
51. Dwivedy, I., Devanesan, P., Cremonesi, P., Rogan, E. and Cavalieri, E. (1992) Synthesis and chacterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem. Res. Toxicol., 5, 828-833.
52. Abul-Hajj, Y.J., Tabakovic, K. and Tabakovic, I. (1995) An estrogen nucleic acid adduct. Electroreductive intermolecular coupling of 3,4-estrone-o-quinone and adenine. J. Am. Chem. Soc., 117, 6144-6145.
53. Han, X. and Liehr, J.G. (1994) 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced Carcinogenesis. Cancer Res., 54, 5515-5517.
54. El-Bayoumy, K., Ji, B.-Y., Upadhyaya, P., Chae, Y.-H., Kurtzke, C., Rivenson, A., Reddy, B.S., Amin, S. and Hecht, S.S. (1996) Lack of tumorigenicity of cholesterol epoxides and estrone-3,4-quinone in rat mammary gland. Cancer Res., 56, 1970-1973.